Turning science into business: Merging AI and RNA
Drug Discovery World
FEBRUARY 27, 2023
For RNA, we’ve seen its success with Covid-19 vaccines and the approval of the first-ever RNA-targeting small molecule, risdiplam, for treating spinal muscular atrophy (SMA). The recent wins with the Covid-19 vaccines and the risdiplam approval demonstrate the potential of RNA. RT : We are just getting started in the RNA space.
Let's personalize your content